Developing better medications for children with HIV
Expertise in Development of Pediatric Drug Formulations
This study is working on developing safe and effective medicines for children with HIV, teaming up with scientists and companies to create new treatments that can help kids stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-10927009 on NIH RePORTER |
What this research studies
This research focuses on creating effective drug formulations specifically designed for children, particularly those affected by HIV. It aims to support the development of new therapeutics and prevention products through collaboration with various scientific and private sector partners. By providing essential research materials and preclinical development support, the project seeks to advance promising products into clinical testing, ensuring they are safe and effective for pediatric use.
Who could benefit from this research
Good fit: Ideal candidates for this research include children aged 0-21 who are living with HIV or are at risk of HIV infection.
Not a fit: Patients who are not within the pediatric age range or those without any risk factors for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and preventive measures for children living with or at risk of HIV.
How similar studies have performed: Previous research has shown success in developing pediatric formulations for other conditions, indicating potential for similar advancements in HIV treatment.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Silvera, Peter — Advanced Bioscience Laboratories, INC.
- Study coordinator: Silvera, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.